Shopping Cart
- Remove All
- Your shopping cart is currently empty
Necrostatin 2 is a necrotic protein and receptor-interacting protein kinase 1 (RIPK1) inhibitor used to study inner ear disorders such as sudden deafness, dizziness and tinnitus.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
1 mg | $57 | In Stock | |
2 mg | $78 | In Stock | |
5 mg | $166 | 5 days | |
1 mL x 10 mM (in DMSO) | $148 | 5 days |
Description | Necrostatin 2 is a necrotic protein and receptor-interacting protein kinase 1 (RIPK1) inhibitor used to study inner ear disorders such as sudden deafness, dizziness and tinnitus. |
Targets&IC50 | Jurkat cells (FADD-deficient human ):50 nM(EC50) |
In vitro | Necrostatin 2 displays activity in a broad range of necroptosis cellular systems. [1] Necrostatin 2 at 30 μM fully protects L929 cells from TNF-α-induced necroptosis. [2] Necrotic apoptosis inhibitory activity was assessed by treating FADD-deficient human Jurkat T cells with TNF-α. Utilizing these conditions the cells efficiently undergo necroptosis, which is completely and selectively inhibited by Necrostatin 2 (EC50=50 nM). [3] |
Alias | Necrostatin2 |
Molecular Weight | 277.71 |
Formula | C13H12ClN3O2 |
Cas No. | 852391-19-6 |
Smiles | C(C=1C=2C(NC1)=C(Cl)C=CC2)[C@@H]3C(=O)N(C)C(=O)N3 |
Relative Density. | 1.450 g/cm3 (Predicted) |
Storage | store at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | |||||||||||||||||||||||||||||||||||
Solubility Information | DMSO: 80 mg/mL(288.07 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
|
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.